Bionano retires all $20M senior secured convertible debentures, eliminating secured debt

Bionano Genomics, Inc.

Retired $20M in senior secured convertible debentures using cash on hand on May 26, 2026.
All liens on company's assets released and restrictive covenants extinguished.
Company now has no outstanding secured debt obligations, providing greater financial flexibility.
Debentures originally issued in May 2024; retirement completes the debt restructuring.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.